Bamlanivimab Treatment Leads to Rapid Selection of Immune Escape Variant Carrying the E484K Mutation in a B.1.1.7-Infected and Immunosuppressed Patient.
作者信息
Lohr Benedikt, Niemann Dirk, Verheyen Jens
机构信息
Koblenz Laboratory, Koblenz, Germany.
Gemeinschaftsklinikum Mittelrhein-Ev. Stift St. Martin, Koblenz, Germany.
出版信息
Clin Infect Dis. 2021 Dec 6;73(11):2144-2145. doi: 10.1093/cid/ciab392.
PMID:34009286
Abstract
摘要
Zotero 插件